SEBCOV study
Vaccines and drugs for the treatment and prevention of COVID-19 require robust evidence generated from clinical trials before they can be used. Public health interventions such as quarantine, self-isolation, social distancing and travel restrictions should also be based on evidence. There are some experiential and mathematical modelling data for these interventions, but there is a lack of data on the social, ethical and behavioural aspects of these interventions.
© Credit Supa-at Asarath
The SEBCOV study which will consist of quantitative surveys and online interviews will be conducted in the United Kingdom, Italy, Slovenia, Malaysia and Thailand. At the time of writing these countries have initiated strict public health measures and varying degrees of “lockdowns” to curb the pandemic. These public health measures will be continued, tightened further, or relaxed in the coming weeks and months. The data generated from our study could inform these strategies in the participating countries in real time.
The quantitative and qualitative findings of the SEBCOV study are available online and free to access. Visit our SEBCOV publications page for a list of our published journal papers and the study protocol.
For a brief summary of the project and the main findings of the cross-country survey, read the interview with Prof Phaik Yeong Cheah on the Sonar-Global website.
Principal investigator
Study team
-
Anne Osterrieder
Engagement Evaluation and Learning Lead
-
Phaik Kin Cheah
Associate Professor
-
Constance Mackworth-Young
Research Fellow
-
Phee Kheng Cheah
Emergency Physician
-
Giulia Cuman
Bioethicist
-
Wirichada Pan-ngum
Associate Professor
-
Mavuto Mukaka
Professor of Medical Statistics and Epidemiology
-
Darlene Ongkili
Emergency Physician
